2016 Annual Meeting | Genetics in Neurology Overview

Date Sunday 04/17/16

Time 06:30 AM - 08:30 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Matthew Harms, MD

Topic(s)

Learning Objectives Participants should obtain a broad overview of neurogenetic advances, familiarity with available tools in diagnostics, current understanding of disease mechanisms underlying hereditary developmental and degenerative neurologic disorders, treatment strategies, and expert opinions on practical and still-evolving approaches to neurogenetic disorders.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Recommended Audience Trainee, General Neurologist, Specialist Neurologist, Non-neurologist

Teaching Styles Case-based, Didactic, Interactive, Audience Participation

Event Timeline
06:30 AM - 06:40 AM		Introduction to Advances in Neurogenetics Matthew Harms, MD
06:40 AM - 07:20 AM		The Genetics of Motor Neuron Disease Matthew Harms, MD
07:20 AM - 07:35 AM		Cases, Questions, and Answers
07:35 AM - 08:15 AM		The Genetic Basis of Dementing Disorders Richard P. Mayeux, MD, MSc, FAAN
08:15 AM - 08:30 AM		Cases, Questions, and Answers

Faculty Disclosures
Matthew Harms, MD	Dr. Harms has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Harms has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Muscular Dystrophy Association. Dr. Harms has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Invitae. Dr. Harms has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Variant Bio. Dr. Harms has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Harms has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx. Dr. Harms has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for uniQure. Dr. Harms has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Littlepage Booth. Dr. Harms has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for O'Connor First. Dr. Harms has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Searcy Denney. Dr. Harms has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Ford, Parshall & Baker LLC . The institution of Dr. Harms has received research support from ALS Association. The institution of Dr. Harms has received research support from Ionis. The institution of Dr. Harms has received research support from ALS Finding a Cure. The institution of Dr. Harms has received research support from Target ALS.
Richard P. Mayeux, MD, MSc, FAAN	Dr. Mayeux has nothing to disclose.

��ɫ��

��ɫ��